The Pharma Industry Is in a Bind. President Donald Trump’s allies are resurfacing a proposal from the first Trump administration that would dramatically cut U.S. drug prices. Nvidia stock rises after ...
Local health officials are hosting free flu vaccine clinics throughout November across eastern Idaho. The clinics by Eastern ...
Moderna’s third quarter was shaped by sharply lower demand for COVID-19 vaccines, yet the company delivered results above ...
Multiple people across the globe who stepped forward are speaking about what they say is the debilitating aftermath they now ...
A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel ...
Mixed earnings results were being mentioned on Thursday as possible catalysts behind Thursday's stock-market action. Shares of Moderna Inc. were up more than 3% after the vaccine maker reported a ...
The company posted a net loss of 51 cents a share, against Wall Street’s expectation for a loss of $2.21. Moderna has ...
Moderna on Thursday also trimmed its adjusted operating expenses outlook for 2025 by $700 million to a range of $5.2 billion to $5.4 billion. Copyright 2025 Thomson Reuters.
As millions of people await their turn to get a COVID-19 vaccine that could be months away, scammers online, in emails and on messaging apps are luring victims with claims they can deliver shots ...
CAMBRIDGE, MA / ACCESS Newswire / November 3, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the first patient has ...
Moderna surged on reports of talks with a large biopharma for a potential partnership or buyout, despite trading at multi-year lows. MRNA's promising cancer vaccine data and surprising findings on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback